$GBTG

Crawley Andrew George sold $6.4M of GBTG

Crawley Andrew George (President) sold 682,662 shares of Global Business Travel Group, Inc. (GBTG) at $9.43 ($6.44M total) across 2 trades over 2026-08-05 to 2026-08-06.

Original reporting
SEC EDGAR · Crawley Andrew George
Published Aug 7, 2026, 8:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GBTG
Neutral
medium confidence
Mentioned
$GBTG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GBTGNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around insider behavior, but there is no new guidance, earnings, or business development in the text.

02

Market read

A disclosed insider open-market sale can influence short-term sentiment, but the filing lacks fundamental new information.

03

What to watch

No 10b5-1 plan is cited, but the filing does not state the reason for sale, and there is no accompanying operational or financial update from the company.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed Aug 7, covering sales on Aug 5-6.

Background

The article is an SEC Form 4 insider transaction disclosure for Global Business Travel Group, Inc. (GBTG).

Company-level read

Ticker impact

$GBTGNeutralMedium confidence
Context

Global Business Travel Group, Inc. insider sold 682,662 shares at $9.43/share in Aug 5-6 trades, per Form 4 filed Aug 7.

Expected impact

Likely limited, sentiment-driven drift rather than a durable repricing.

Evidence & confidence

Form 4 shows a direct sale by the President with no 10b5-1 plan stated; however, insider sales are common and the filing provides no new company performance or guidance.

Market effects

Minimal. This is an individual insider transaction, not a sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity management (taxes, diversification) and not a bearish signal, especially since the trades are spread across two days at the same price.

Key entities

  • Global Business Travel Group, Inc.

    Subject of the Form 4 insider sale by its President.

  • Crawley Andrew George

    President who sold 682,662 shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HRLMedAI 8/10

Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankrupt

Hormel (HRL) acquires Brakebush for $1.06B; Onsemi (ON) to buy Synaptics for $5.7B; Leslie's files for bankruptcy. Valley National (VLY) to acquire Bluevine for $340M. Yext (YEXT) to acquire Flamel.ai. Lifecore (LFCR) to be acquired by Webster Equity for up to $663.7M. SoftBank completes DigitalBridge acquisition. GBTG acquired by Long Lake for $6.3B.

$INTUMed

Q2 Earnings Highs And Lows: Intuit (NASDAQ:INTU) Vs The Rest Of The Finance and HR Software Stocks

Intuit (INTU) reported Q2 revenue of $4.35B, up 13.7% YoY, but missed EPS guidance, causing shares to drop 12.5%. American Express Global Business Travel (GBTG) saw 37.9% revenue growth, beating estimates. Marqeta (MQ) reported $176M revenue, up 17% YoY, but missed guidance. Paylocity (PCTY) beat estimates with 11% growth. BlackLine (BL) reported $187.8M revenue, in line with expectations but down 13.2% post-earnings.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).